Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Human Gene Therapy|April 2, 2021
Generation of Epstein-Barr Virus Antigen-Specific T Cell Receptors Recognizing Immunodominant Epitopes of LMP1, LMP2A, and EBNA3C for ImmunotherapyKrystyna Dudaniec, Kerstin Westendorf, Elfriede Nössner, et al.International Journal of Cancer|January 29, 2008
Antitumor effector functions of T cells are dependent on in vivo priming and restricted T-cell receptor expressionCarolin Lüking, Konrad Kronenberger, Bernhard Frankenberger, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemiaKonrad Kronenberger, Elfriede Nössner, Bernhard Frankenberger, et al.Journal of Molecular Medicine (Berlin, Germany)|March 10, 2009
Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinomaChristiane Geiger, Elfriede Nössner, Bernhard Frankenberger, et al.Cancer Letters|March 7, 2006
Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemiaThomas Allgeier, Silke Garhammer, Elfriede Nössner, et al.Plos Pathogens|May 30, 2015
The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene ActivationAnders Friberg, Sybille Thumann, Janosch Hennig, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: preclinical evaluationUlrich Wahl, Elfriede Nössner, Konrad Kronenberger, et al.Blood|July 14, 2007
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignanciesIngrid G Schuster, Dirk H Busch, Elfriede Eppinger, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 9, 2024
Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functionsAlexander Tamalunas, Amin Wendt, Florian Springer, et al.Translational Lung Cancer Research|August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker studyLukas Käsmann, Julian Taugner, Chukwuka Eze, et al.Pageof 1